Delivery Order SPE2DB20D3103-SPE2DB23FP5M8
Award Date
8/29/23
Potential Completion Date
9/20/23
Potential Value
$27K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,886.60 Firm Fixed Price delivery order is for the procurement of VEKLURY 100 MG VIALS, a critical pharmaceutical product. The contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,566.90, is for the supply of VEKLURY 100 MG VIALS, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of January 2, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,817.84 for the provision of VEKLURY 100 MG VIALS, a critical pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $20,427.60 firm fixed-price delivery order is for the supply of VEKLURY 100 mg vials, a pharmaceutical product used to treat COVID-19. The contract has an ultimate completion date of August 2, 2024 and does not utilize a set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of VEKLURY 100 MG VIALS, a pharmaceutical product. The contract is not set aside and has a firm fixed price with a ceiling value of $3,962.10. The contract has an ultimate completion date of June 25, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of VEKLURY 100 MG vials to the Defense Logistics Agency (DLA). The firm fixed price delivery order, valued at $4,085.52, has a completion date of March 18, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this contract, which is not designated as a set-aside. The company also holds an indefinite delivery contract (IDC) with a...
This federal contract award is for the pharmaceutical product VEKLURY 100 MG VIALS, awarded to Amerisourcebergen Drug Corp's Corporate Office Division. The $6,809.20 firm fixed-price delivery order was placed by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). This contract does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $2,042.76, is for the supply of VEKLURY 100 MG VIALS, a pharmaceutical product. The contract is a firm fixed-price arrangement with a completion date of September 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which enables the...
This federal contract award is for the delivery of Veklury 100 mg vials to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on October 24, 2023, with a ceiling value of $2,041.02. The contract is a firm-fixed-price delivery order with a completion date of November 15, 2023. The award is not designated as a set-aside contract....
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide VEKLURY 100 MG VIALS. The $10,213.80 contract has a completion date of February 29, 2024 and does not utilize a set-aside designation. Amerisourcebergen Drug Corp serves as the prime contractor for this award, which is part of a larger indefinite delivery contract with DLA valued up to $999,999,999.00 through...